AS03-adjuvanted H7N9 inactivated split virion vaccines induce cross-reactive and protective responses in ferrets
Sign Up to like & getrecommendations! Published in 2021 at "NPJ Vaccines"
DOI: 10.1038/s41541-021-00299-3
Abstract: Human infections with avian H7N9 subtype influenza viruses are a major public health concern and vaccines against H7N9 are urgently needed for pandemic preparedness. In early 2013, novel H7N9 influenza viruses emerged in China that… read more here.
Keywords: split virion; as03 adjuvanted; adjuvanted h7n9; virion vaccines ... See more keywords
Clinical phase II and III studies of an AS03‐adjuvanted H5N1 influenza vaccine produced in an EB66® cell culture platform
Sign Up to like & getrecommendations! Published in 2020 at "Influenza and Other Respiratory Viruses"
DOI: 10.1111/irv.12755
Abstract: We have developed an AS03‐adjuvanted H5N1 influenza vaccine produced in an EB66® cell culture platform (KD‐295). read more here.
Keywords: influenza vaccine; as03 adjuvanted; vaccine produced; adjuvanted h5n1 ... See more keywords
Reassessment of the risk of narcolepsy in children in England 8 years after receipt of the AS03-adjuvanted H1N1 pandemic vaccine: A case-coverage study
Sign Up to like & getrecommendations! Published in 2020 at "PLoS Medicine"
DOI: 10.1371/journal.pmed.1003225
Abstract: Background Early studies of narcolepsy after AS03-adjuvanted pandemic A/H1N12009 vaccine (Pandemrix) could not define the duration of elevated risk post-vaccination nor the risk in children aged under 5 years who may not present until much… read more here.
Keywords: risk; reassessment risk; as03 adjuvanted; vaccine ... See more keywords